Extracorporeal shock wave lithotripsy in primary hyperoxaluria

Kamoun, A; Mohamed, Chbil; Rachid, Lakhoua Mohamed

doi:10.1016/s0140-6736(94)90724-2

The Lancet

1994

DOI: 10.1016/s0140-6736(94)90724-2

|View full text |Cite

Extracorporeal shock wave lithotripsy in primary hyperoxaluria

A Kamoun¹,

Chbil Mohamed²,

Lakhoua Mohamed Rachid³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2005

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is unclear, however, whether deterioration in renal function is a direct result of treatment with SWL, or is coincidental and due to natural progression of the disease. Subsequent reports have demonstrated varying success in treatment of calculi in patients with PH without effect on renal function [ 11 – 13 ]. Al-Abadi and Hulton reported 23 stones in 10 PH patients who underwent SWL, and while no deterioration in renal function was noted, only 20% of PH type 1 (PH1) stones showed improvement [ 13 ].…”

mentioning

confidence: 99%

Primary hyperoxaluria type 1: urologic and therapeutic management

Kohli

Kurtz

2022

Clinical Kidney Journal

View full text Add to dashboard Cite

While the surgical approaches available in primary hyperoxaluria (PH) are common to all patients requiring intervention for urolithiasis, the indications for treatment and their corresponding toxicities are unique. Being a rare disease, we are guided by case series. This review summarizes the available literature highlighting the important disease-specific considerations. Shockwave lithotripsy (SWL) is of particular interest. It is generally the first-line treatment for stones in children, but here the stones produced will be relatively resistant to fragmentation. In addition, there are concerning reports in children of sudden unilateral decline in function in the treated kidney as measured by nuclear renography. Percutaneous nephrostolithotomy might intuitively seem favorable given the shortest drain duration and the ability to treat larger stones efficiently but, similar to SWL, rapid chronic kidney disease (CKD) progression has been seen postoperatively. Ureteroscopy is therefore generally the safest option, but considerations regarding stent encrustation, the growth of residual fragments and the large volume of stone often faced may limit this approach. The surgeon must balance the above with consideration of the patient's CKD status when considering a plan of monitoring and treating stones in PH.

show abstract

mentioning

confidence: 99%

Primary hyperoxaluria type 1: urologic and therapeutic management

Kohli

Kurtz

2022

Clinical Kidney Journal

View full text Add to dashboard Cite

show abstract

Pitfalls in the management of patients with primary hyperoxaluria: a urologist’s perspective

Pais

Assimos

2005

Urol Res

View full text Add to dashboard Cite

The primary hyperoxalurias are rare, inherited diseases which commonly manifest early in life as urolithiasis. As these patients often present to the urologic surgeon, it is imperative that urologists understand the typical presentation, diagnosis, and management of urolithiasis associated with primary hyperoxaluria. In this review, the pertinent epidemiology and pathogenesis as they relate to the diagnosis and natural history of the disease are discussed. The literature on therapeutic options for primary hyperoxaluric patients with calculi is examined, and treatment strategies are suggested.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Extracorporeal shock wave lithotripsy in primary hyperoxaluria

Cited by 2 publications

References 3 publications

Primary hyperoxaluria type 1: urologic and therapeutic management

Primary hyperoxaluria type 1: urologic and therapeutic management

Pitfalls in the management of patients with primary hyperoxaluria: a urologist’s perspective

Contact Info

Product

Resources

About